JANX007

· Janux Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JANX007, covering 2026-01-20 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) [Phase 1]